FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS
|
0.430 |
GeneticVariation
|
disease |
UNIPROT |
NHLRC2 variants identified in patients with fibrosis, neurodegeneration, and cerebral angiomatosis (FINCA): characterisation of a novel cerebropulmonary disease.
|
29423877 |
2018 |
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
Mutations of NHLRC2, including Asp148Tyr, have been recently associated with a novel FINCA disease (fibrosis, neurodegeneration, cerebral angiomatosis), which is fatal in early childhood.
|
30138417 |
2018 |
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
Fibrosis, neurodegeneration and cerebral angiomatosis (FINCA disease) have been described in patients with mutations in NHL repeat-containing protein 2 (NHLRC2).
|
30239752 |
2018 |
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
NHLRC2 variants identified in patients with fibrosis, neurodegeneration, and cerebral angiomatosis (FINCA): characterisation of a novel cerebropulmonary disease.
|
29423877 |
2018 |
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS
|
0.430 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Atelectasis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Diarrhea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dystonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Elliptocytosis, Hereditary
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cardiomegaly
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hepatomegaly
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Irritable Mood
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Quadriplegia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Respiratory Insufficiency
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Strabismus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Reticulocytosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Anisocytosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Tachypnea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Feeding difficulties
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Recurrent infections
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypoplasia of corpus callosum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Elliptocytosis found
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|